Twist Bioscience Corp (TWST) poses a Brand-New Opportunity for Investors with beta value of 1.66

Twist Bioscience Corp (NASDAQ: TWST) flaunted slowness of -0.14% at $28.57, before settling in for the price of $28.61 at the close. Taking a more long-term approach, TWST posted a 52-week range of $11.46-$43.21.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The Healthcare sector firm’s twelve-monthly sales growth has been 60.13% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -6.09%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 14.54%. This publicly-traded company’s shares outstanding now amounts to $57.56 million, simultaneously with a float of $55.30 million. The organization now has a market capitalization sitting at $1.65 billion. At the time of writing, stock’s 50-day Moving Average stood at $35.79, while the 200-day Moving Average is $27.28.

Twist Bioscience Corp (TWST) Ownership Facts and Figures

Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Twist Bioscience Corp industry. Twist Bioscience Corp’s current insider ownership accounts for 4.36%, in contrast to 108.71% institutional ownership. According to the most recent insider trade that took place on Apr 09 ’24, this organization’s Chief Financial Officer sold 556 shares at the rate of 33.16, making the entire transaction reach 18,434 in total value, affecting insider ownership by 74,444. Preceding that transaction, on Apr 02 ’24, Company’s Chief Executive Officer sold 1,132 for 32.74, making the whole transaction’s value amount to 37,057. This particular insider is now the holder of 514,149 in total.

Twist Bioscience Corp (TWST) Earnings and Revenue Records

Twist Bioscience Corp’s EPS increase for this current 12-month fiscal period is 14.54% and is forecasted to reach -2.67 in the upcoming year.

Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators

Let’s observe the current performance indicators for Twist Bioscience Corp (TWST). It’s Quick Ratio in the last reported quarter now stands at 5.51. The Stock has managed to achieve an average true range (ATR) of 1.78. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.30.

In the same vein, TWST’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.60, a figure that is expected to reach -0.81 in the next quarter, and analysts are predicting that it will be -2.67 at the market close of one year from today.

Technical Analysis of Twist Bioscience Corp (TWST)

Now, what If we examine the latest scores posted by [Twist Bioscience Corp, TWST]. During the last 5-days, its volume was lower the volume of 0.92 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 9.24% While, its Average True Range was 1.69.

Raw Stochastic average of Twist Bioscience Corp (TWST) in the period of the previous 100 days is set at 27.31%, which indicates a major rise in contrast to 9.82% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 47.73% that was lower than 63.12% volatility it exhibited in the past 100-days period.